InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by GOLDSTEIN JOSEPH L, Director. Officer active across 1 companies, notably Regeneron Pharmaceuticals, INC.. In total, 7 disclosures have been recorded. The latest transaction was filed on 30 March 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations7 total
€814,8172,431 shares@ €335.17790.0011% mcap22.7% of flow
Common Stock
SEC:0001883850-22-000032:0·
0191 shares0
Common Stock
SEC:0001708138-22-000006·
0191 shares0
Common Stock
SEC:0001708138-22-000006:0·
€798,5642,479 shares@ €322.13130.0011% mcap57.4% of flow
Common Stock
SEC:0001708138-21-000076·
€798,5642,479 shares@ €322.13130.0011% mcap22.2% of flow
Common Stock
SEC:0001708138-21-000076:0·
€592,1551,930 shares@ €306.81580.0008% mcap42.6% of flow
Common Stock
SEC:0001237899-21-000008·
€592,1551,930 shares@ €306.81580.0008% mcap16.5% of flow
Common Stock
SEC:0001237899-21-000008:0·
7 of 7 declarations
About GOLDSTEIN JOSEPH L
Joseph L. Goldstein serves as a Director at REGENERON PHARMACEUTICALS, INC. In this role, he contributes to the governance of the company and oversight of its operations. Goldstein plays a key role in developing the strategies and policies that guide the company in the pharmaceutical sector, ensuring that shareholder interests are protected.
